Navigation Links
Toll-like receptors play role in brain damage in newborns
Date:11/23/2011

Two out of every thousand babies are at risk of brain damage in connection with birth. Researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden, have identified mechanisms behind these injuries, which could lead to better treatment and a richer life for the infants affected. Roughly two in every thousand babies are at risk of suffering brain damage as a result of events before, during and after delivery. Infections in the blood or a reduced supply of oxygen and blood can lead to inflammation in the brain, causing injury. This type of brain damage, which is much more common in premature babies, can result in neurological problems such as cerebral palsy, learning difficulties and epilepsy.

Toll-like receptors

Researchers at the University of Gothenburg's Sahlgrenska Academy have now found that toll-like receptors (TLRs) in the innate immune system play a major role in the state of the brain in newborns. The discovery could lead to better treatment and a richer life for many children.

Key role in the immature brain

Research into TLRs, which was rewarded with this year's Nobel Prize in Physiology or Medicine, has previously shown that these receptors are involved in stroke-related brain damage in adults. The researchers in Gothenburg have now shown that TLRs are also present in the immature brain and play an important role there. "By understanding the role of toll-like receptors in the inflammatory process following brain injury, we hope eventually to find more effective treatment strategies," says Linnea Stridh from the Sahlgrenska Academy, who presents the results in her thesis.

Simulated brain injuries

Stridh and her colleagues used mice in their studies to simulate the brain injuries seen in newborn babies. They found that special TLRs contribute to brain damage following hypoxia, where the brain is starved of oxygen. "An infection can activate these receptors, making the brain more sensitive to hypoxia, resulting in worse brain damage," Stridh explains. "If these signals are blocked, the degree of brain damage is reduced."

Barrier opened

In her thesis, Stridh also looks at a protein called occludin, which has the role of gluing together cells in the blood-brain barrier.

"Our results show that there is a reduction in occludin at a genetic level following infection," she explains. "This can lead to the opening of the barrier, making it easier for inflammatory molecules and cells in the blood to get into the brain and cause inflammation."


'/>"/>
Contact: Linnea Stridh
linnea.stridh@neuro.gu.se
46-031-786-3377
University of Gothenburg
Source:Eurekalert  

Related medicine news :

1. Folate receptors may serve as a front door to ovarian cancer treatment
2. Nuclear receptors battle it out during metamorphosis in new fruit fly model
3. Historic first images of rod photoreceptors in the living human eye
4. Researchers get a grip on nervous systems receptors
5. Targeting nicotine receptors to treat cognitive impairments in schizophrenia
6. Nuclear receptors reveal possible interventions for cancer, obesity
7. New drug targets vitamin D receptors in hormone resistant prostate cancers
8. Bitter Taste Receptors Found in Lungs May Aid Asthma Patients
9. Cedars-Sinai study: How does a good protein hurt brain cells after clot-induced stroke?
10. Enhanced treatment of brain tumors
11. Meditation Can Turn Off Regions of the Brain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Toll-like receptors play role in brain damage in newborns
(Date:3/29/2017)... ... March 29, 2017 , ... Curio Wellness , a premium medical cannabis ... the company’s executive management team with prominent executives from both inside and outside the ... Operating Officer, Ted Dumbauld , who has more than twenty years of business ...
(Date:3/29/2017)... ... ... Hamlin Dental Group, multi-location dental office in North Hollywood , Van ... safe and effective options, and can be used alone or in conjunction with other ... care. , Dr. Hamid Reza of Hamlin Dental Group offers other treatments as well, ...
(Date:3/29/2017)... ... March 29, 2017 , ... VisualSP has helped over 1.5 million ... only option for on-premises installation of its Help System for SharePoint was at the ... system into the entire tenant. , The company recently released a modified version ...
(Date:3/28/2017)... SEATTLE, Washington and CARTERSVILLE, Georgia (PRWEB) , ... ... ... adding another senior analyst to its award-winning team. Ruel Williamson brings his extensive ... Advisors, which has been a leader in the real estate valuation industry for ...
(Date:3/28/2017)... ... March 28, 2017 , ... City trips have ... World Travel Trends Report). As travelers visit both urban destinations, they are faced ... prolonged sun exposure. In response, the outdoor industry has blurred the lines between ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017  Glenmark Pharmaceuticals, a global pharmaceutical company, ... investigational fixed-dose combination of mometasone furoate (25 mcg) ... a nasal spray being studied for the treatment ... a recently completed Phase 3 trial assessing the ... versus mometasone, olopatadine or placebo. "We ...
(Date:3/29/2017)... , March 29, 2017  Maxor National Pharmacy ... announced that it has named Leah Bailey ... all divisions of the company. With more ... the previous 8 years focused on health care, Bailey ... her tenure at Prime, Bailey advised the PBM, Specialty, ...
(Date:3/29/2017)... Varian Medical Systems (NYSE: VAR ) ... quarter of fiscal year 2017 following the close of regular ... be followed by a teleconference available to all interested parties ... to the conference call webcast will be available on the ... call and replay: ...
Breaking Medicine Technology: